Publication | Closed Access

Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4–NF-κB signaling

InflammationNanoparticlesAnti-inflammatoryEngineeringProtein NanoparticlesImmunologyTlr4–nf-κb SignalingNano-drug DeliveryInnate ImmunityMedicineGlycol-split Heparin NanoparticlesBiomolecular EngineeringLipopolysaccharide-induced Inflammation